<?xml version="1.0" encoding="UTF-8"?>
<ref id="feb213806-bib-0047">
 <label>47</label>
 <mixed-citation publication-type="journal" id="feb213806-cit-0047">
  <string-name>
   <surname>Zhu</surname>
   <given-names>L</given-names>
  </string-name>, 
  <string-name>
   <surname>George</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Schmidt</surname>
   <given-names>MF</given-names>
  </string-name>, 
  <string-name>
   <surname>Al‐Gharabli</surname>
   <given-names>SI</given-names>
  </string-name>, 
  <string-name>
   <surname>Rademann</surname>
   <given-names>J</given-names>
  </string-name> and 
  <string-name>
   <surname>Hilgenfeld</surname>
   <given-names>R</given-names>
  </string-name> (
  <year>2011</year>) 
  <article-title>Peptide aldehyde inhibitors challenge the substrate specificity of the SARS‐coronavirus main protease</article-title>. 
  <source xml:lang="en">Antiviral Res</source>
  <volume>92</volume>, 
  <fpage>204</fpage>–
  <lpage>212</lpage>.
  <pub-id pub-id-type="pmid">21854807</pub-id>
 </mixed-citation>
</ref>
